ARCHIVES

FDA Approves Cyramza for Stomach Cancer; Zykadia in NSCLC; Lipiodol for HCC Imaging; And Cobas HPV Test for Primary Screening

This article is from The Cancer Letter archive.

Vol. 37 No. 4 | April 25, 2014

Download PDF Visit The Full Archive

Related Articles

NCI, American Cancer Society Re-Evaluating Join Guidelines On Mammography Screening

September 17, 1993

FDA Approves Rituxan For CLL

February 19, 2010

NCI, FDA Courting Drug Sponsors To Add Clinical Trials To PDQ Database

October 11, 1996

In Brief: Durant New President Of AACI, Ultmann Named President-Elect; Farber Center Gets New Name

February 4, 1983

Guest Editorial: FDA Must Address Economic Incentives to Resolve Drug Shortages Permanently

February 24, 2012

Tobacco Control Bill Requires Stronger Warnings

August 10, 1990